NANOBIOTIX Announces Positive First Clinical Data Showing Conversion of Anti-PD-1 Non-Responders to Responders With Radioenhancer NBTXR3
Data presented at The Society for the Immunotherapy of Cancer 35th Anniversary Annual Meeting Eight of nine patients treated on…